Oral Glucose Loading Modulates Plasma β-Amyloid Level in Alzheimer’s Disease Patients: Potential Diagnostic Method for Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|34|1|25-30

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.34, Iss.1, 2012-08, pp. : 25-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-08 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Progression of Mild Cognitive Impairment to Alzheimer’s Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and β-Amyloid(1–42) Levels

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-07 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

T Cell Response to Amyloid-β and to Mitochondrial Antigens in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 1, 2003-05 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite